1. Osborne NN, Chidlow G, Nash MS, Wood JP. The potential of neuroprotection in glaucoma treatment. Curr Opin Ophthalmol 1999; 10: 82-92
  2. Pache M, Flammer J. A sick eye in a sick body? Systemic findings in patients with primary open-angle glaucoma. Surv Ophthalmol 2006; 51: 179-212
  3. Cybulska-Heinrich AK, Mozaffarieh M, Flammer J. Ginkgo biloba: an adjuvant therapy for progressive normal and high tension glaucoma. Mol Vis 2012 18: 390-402
  4. Marcus DF, Krupin T, Podos SM, Becker B. The effect of exercise on intraocular pressure. I. Human beings. Invest Ophthalmol 1970; 9: 749-752
  5. Pasquale LR, Kang JH. Lifestyle, nutrition, and glaucoma. J Glaucoma 2009; 18: 423-428
  6. Ramdas WD, Wolfs RC, Hofman A, de Jong PT, Vingerling JR, Jansonius NM. Lifestyle and risk of developing open-angle glaucoma: the Rotterdam study. Arch Ophthalmol 2011; 129: 767-772
  7. Law SK, Li T. Acupuncture for glaucoma. Cochrane Database Syst Rev 2007; 4: CD006030
  8. Osborne NN. Recent clinical findings with memantine should not mean that the idea of neuroprotection in glaucoma is abandoned. Acta Ophthalmol 2009: 87: 450–454
  9. Parikh RS, Parikh SR. Alternative therapy in glaucoma management: is there any role? Indian J Ophthalmol 2011; 59 Suppl: S158-S160
  10. Sena DF, Ramchand K, Lindsley K. Neuroprotection for treatment of glaucoma in adults. Cochrane Database Syst Rev 2010; 2: CD006539
Dezembro 2012